In recent years, there has been significant progress made in CF treatment and outcomes with the advent of cystic fibrosis transmembrane conductance regulator (CFTR) modulators [3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]. This evidence concerns the gene CFTR and cystic fibrosis.